IVVD
Price:
$0.9699
Market Cap:
$128.73M
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vac...[Read more]
Industry
Biotechnology
IPO Date
2021-08-06
Stock Exchange
NASDAQ
Ticker
IVVD
According to Invivyd, Inc.’s latest financial reports and current stock price. The company's current ROE is -53.48%. This represents a change of 203.48% compared to the average of -17.62% of the last 4 quarters.
The mean historical ROE of Invivyd, Inc. over the last ten years is -53.68%. The current -53.48% ROE has changed -0.38% with respect to the historical average. Over the past ten years (40 quarters), IVVD's ROE was at its highest in in the December 2020 quarter at 97.89%. The ROE was at its lowest in in the September 2024 quarter at -73.04%.
Average
-53.68%
Median
-54.22%
Minimum
-251.60%
Maximum
171.61%
Discovering the peaks and valleys of Invivyd, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.78%
Maximum Annual ROE = 171.61%
Minimum Annual Increase = -123.68%
Minimum Annual ROE = -251.60%
| Year | ROE | Change |
|---|---|---|
| 2025 | -21.73% | -91.36% |
| 2024 | -251.60% | 124.78% |
| 2023 | -111.93% | 65.11% |
| 2022 | -67.79% | 66.80% |
| 2021 | -40.64% | -123.68% |
The current ROE of Invivyd, Inc. (IVVD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-128.42%
5-year avg
-98.74%
10-year avg
-53.68%
Invivyd, Inc.’s ROE is greater than OmniAb, Inc. (-20.31%), greater than Genfit S.A. (-596.44%), greater than C4 Therapeutics, Inc. (-50.68%), greater than Protara Therapeutics, Inc. (-38.70%), less than Insight Molecular Diagnostics Inc. (380.80%), less than Sangamo Therapeutics, Inc. (6.69%), greater than Codexis, Inc. (-68.09%), less than Neonc Technologies Holdings, Inc. (284.28%), greater than Orchestra BioMed Holdings, Inc. (-137.99%), greater than SELLAS Life Sciences Group, Inc. (-47.12%),
| Company | ROE | Market cap |
|---|---|---|
| -20.31% | $278.67M | |
| -596.44% | $445.68M | |
| -50.68% | $343.73M | |
| -38.70% | $153.59M | |
| 380.80% | $146.02M | |
| 6.69% | $70.43M | |
| -68.09% | $233.60M | |
| 284.28% | $105.37M | |
| -137.99% | $238.92M | |
| -47.12% | $1.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invivyd, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invivyd, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Invivyd, Inc.'s ROE?
How is the ROE calculated for Invivyd, Inc. (IVVD)?
What is the highest ROE for Invivyd, Inc. (IVVD)?
What is the 3-year average ROE for Invivyd, Inc. (IVVD)?
What is the 5-year average ROE for Invivyd, Inc. (IVVD)?
How does the current ROE for Invivyd, Inc. (IVVD) compare to its historical average?